Key Points
RSV vaccines hold the potential to reduce the thousands of hospitalizations and deaths associated with the virus in the US each year..
There are now three vaccines available in the USGSKs Arexvy and Modernas mRESVIA are approved for use in older adults, and Pfizers Abrysvo for older adults and pregnant womenbut already, disparities are emerging in their uptake..
Though the CDC recommends an RSV vaccine to everyone 75 or older, so far this year only 19 percent of Hispanic people in this age group have been vaccinated, compared to 35 percent of white, 31 percent of Asian, and 24 percent of Black seniors...
This worries Marquez, who witnessed how varied access and confidence in Covid-19 vaccines may have worsened health outcomes for Latino and Black Americans during the pandemic..
As this is a new vaccine for our elders, we need to understand the most effective approaches to facilitate uptake, says Diane Havlir, chief of the Zuckerberg San Francisco General Hospitals HIV and infectious diseases division, who is assisting with the study..
You might be interested in
US FDA approves world's first RSV vaccine. All you need to know
04, May, 23After the FDA nod, GSK's shot, called Arexvy, becomes the first vaccine to protect older adults against RSV.
US CDC OKs use of new Pfizer, GSK vaccines for RSV in older adults
29, Jun, 23The director of the U.S. Centers for Disease Control and Prevention on Thursday signed off on the use of new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections in older adults.